Form 8-K - Current report:
SEC Accession No. 0001193125-25-052940
Filing Date
2025-03-12
Accepted
2025-03-12 16:18:45
Documents
16
Period of Report
2025-03-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d347915d8k.htm   iXBRL 8-K 46207
2 EX-99.2 d347915dex992.htm EX-99.2 13131
6 GRAPHIC g347915g0312084931901.jpg GRAPHIC 1885
7 GRAPHIC g347915g0312084932113.jpg GRAPHIC 1635
  Complete submission text file 0001193125-25-052940.txt   201074

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20250312.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20250312_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20250312_pre.xml EX-101.PRE 11708
19 EXTRACTED XBRL INSTANCE DOCUMENT d347915d8k_htm.xml XML 3804
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 25731998
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)